Intraclass Switching among IL17 Inhibitors in Psoriasis: A Real-Life, Long-Term Single-Center Experience
Sign Up to like & getrecommendations! Published in 2023 at "Dermatologic Therapy"
DOI: 10.1155/2023/5557255
Abstract: Interleukin 17 (IL-17) inhibitors such as secukinumab, ixekizumab, and IL17 receptor (IL17RA) inhibitor brodalumab have proved to be highly effective and safe in psoriasis treatment. Still, a substantial proportion of patients show a primary or… read more here.
Keywords: switching among; intraclass switch; intraclass; among inhibitors ... See more keywords